by Stacey Johnson | Mar 17, 2023
Toronto, Canada’s Tak Mak, OC, OOnt, FRS, FRSC, has won the prestigious Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research, valued at US$100,000. Dr. Mak, who has his lab at the Princess Margaret Cancer Centre (PMCC), is...				
					
			
					
				
															
					
					 by Stacey Johnson | Dec 16, 2022
Back in 2014, Selena Gomez was diagnosed with lupus. The singer and actress has been public about getting chemotherapy to treat her condition, and her kidney transplant. The autoimmune disease causes the immune system to attack the body’s tissues and organs....				
					
			
					
				
															
					
					 by Lyla El-Fayomi | Jul 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I sample the latest and greatest findings in recent press and package them into a single post. In this double issue, I cover a gene therapy for...				
					
			
					
				
															
					
					 by Lyla El-Fayomi | May 10, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. April was full of great research and big...				
					
			
					
				
															
					
					 by Sara M. Nolte | Apr 28, 2022
If I were to ask you to think of a genetic disease that should be a priority for gene therapy research, you might say breast cancer, Huntington’s, or cystic fibrosis. And these are all great candidates. But I’d say you’re missing a big one. Sickle cell disease (SCD)...				
					
			
					
				
															
					
					 by Krystal Jacques | Apr 21, 2022
It’s been all over the news for the last two weeks. Diljeet Gill and colleagues at the Babraham Institute in England are investigating a novel way to reverse aging of skin, opening the door to creating a new possible cell therapy. Their work largely originates from...				
					
						 
Comments